| pubmed-article:9132980 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9132980 | lifeskim:mentions | umls-concept:C0027573 | lld:lifeskim |
| pubmed-article:9132980 | lifeskim:mentions | umls-concept:C0080194 | lld:lifeskim |
| pubmed-article:9132980 | lifeskim:mentions | umls-concept:C0427965 | lld:lifeskim |
| pubmed-article:9132980 | lifeskim:mentions | umls-concept:C0039725 | lld:lifeskim |
| pubmed-article:9132980 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9132980 | pubmed:dateCreated | 1997-5-1 | lld:pubmed |
| pubmed-article:9132980 | pubmed:abstractText | Failure of uncomplicated gonococcal infections acquired in the Far East to respond to doses of ciprofloxacin and ofloxacin recommended by the Centers for Disease Control and Prevention have been identified in Australia, the United Kingdom, and the United States. In the Republic of the Philippines, 54.3% of strains exhibited decreased susceptibility to fluoroquinolones; 12% of strains were resistant to ciprofloxacin. This study was undertaken to compare the antimicrobial susceptibilities of gonococcal isolates in Bangkok, Thailand, with those in the Republic of the Philippines. | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9132980 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9132980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9132980 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9132980 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9132980 | pubmed:issn | 0148-5717 | lld:pubmed |
| pubmed-article:9132980 | pubmed:author | pubmed-author:KnappJ SJS | lld:pubmed |
| pubmed-article:9132980 | pubmed:author | pubmed-author:YoungN LNL | lld:pubmed |
| pubmed-article:9132980 | pubmed:author | pubmed-author:ChitwarakornA... | lld:pubmed |
| pubmed-article:9132980 | pubmed:author | pubmed-author:WongbaCC | lld:pubmed |
| pubmed-article:9132980 | pubmed:author | pubmed-author:MastroT DTD | lld:pubmed |
| pubmed-article:9132980 | pubmed:author | pubmed-author:Limpakarnjana... | lld:pubmed |
| pubmed-article:9132980 | pubmed:author | pubmed-author:BuatiangAA | lld:pubmed |
| pubmed-article:9132980 | pubmed:author | pubmed-author:ParekhM CMC | lld:pubmed |
| pubmed-article:9132980 | pubmed:author | pubmed-author:P'anS YSY | lld:pubmed |
| pubmed-article:9132980 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9132980 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:9132980 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9132980 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9132980 | pubmed:pagination | 142-8 | lld:pubmed |
| pubmed-article:9132980 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:9132980 | pubmed:otherAbstract | PIP: To assess the frequency and diversity of antimicrobial resistant strains of Neisseria gonorrhoeae in Thailand, endocervical or urethral strains were isolated from 101 patients at a Bangkok sexually transmitted disease clinic. Of the 101 strains, 90 (89.1%) were resistant to penicillin or tetracycline. Plasmid-mediated resistance to penicillin or tetracycline was found in 33.7% of isolates; this included penicillinase-producing N gonorrhoeae (17.8%), tetracycline-resistant N gonorrhoeae (7.9%), and penicillinase-producing/tetracycline-resistant N gonorrhoeae (7.9%). Moreover, 51.5% of all strains exhibited chromosomally mediated resistance to penicillin and tetracycline. All strains were susceptible to spectinomycin. 22 strains (21.8%) showed decreased susceptibility to ciprofloxacin, while another fifth demonstrated resistance to both fluoroquinolones and norfloxacin. Finally, more than 75% of strains exhibited decreased susceptibility to kanamycin and thiamphenicol. The penicillin/tetracycline resistance phenotypes identified in Bangkok were more similar to those of isolates in the US than in the Philippines, where decreased susceptibility to fluoroquinolones predominates. Given evidence of antimicrobial resistance to penicillin, tetracycline, kanamycin, thiamphenicol, and fluoroquinolones in Thailand, the choice of agents for the treatment of uncomplicated gonococcal infection should be considered carefully and periodic surveillance of antimicrobial resistance is recommended to permit timely revision of treatment protocols. | lld:pubmed |
| pubmed-article:9132980 | pubmed:meshHeading | pubmed-meshheading:9132980-... | lld:pubmed |
| pubmed-article:9132980 | pubmed:meshHeading | pubmed-meshheading:9132980-... | lld:pubmed |
| pubmed-article:9132980 | pubmed:meshHeading | pubmed-meshheading:9132980-... | lld:pubmed |
| pubmed-article:9132980 | pubmed:meshHeading | pubmed-meshheading:9132980-... | lld:pubmed |
| pubmed-article:9132980 | pubmed:meshHeading | pubmed-meshheading:9132980-... | lld:pubmed |
| pubmed-article:9132980 | pubmed:meshHeading | pubmed-meshheading:9132980-... | lld:pubmed |
| pubmed-article:9132980 | pubmed:meshHeading | pubmed-meshheading:9132980-... | lld:pubmed |
| pubmed-article:9132980 | pubmed:meshHeading | pubmed-meshheading:9132980-... | lld:pubmed |
| pubmed-article:9132980 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9132980 | pubmed:articleTitle | Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995. | lld:pubmed |
| pubmed-article:9132980 | pubmed:affiliation | Division of AIDS, STD, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. | lld:pubmed |
| pubmed-article:9132980 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9132980 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9132980 | lld:pubmed |
